GGrantIndex
Sort

166,118 grants matching stem cells

Alveolar Tissuegenesis in Murine Acute Lung Injury

$976,312
William J. Martin · Environmental Health Sciences · Z01 · FY2007 · ES

Animal models to study the role of INK4b loss in human acute myeloid leukemia

$976,228
Linda Wolff · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

CAREER: Domesticated Retroviral Envelope Genes in Eukaryotic Genomes

$976,125
Harmit S Malik · Fred Hutchinson Cancer Research Center · · FY2008 · BIO

Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema

$976,079
Susan M Majka · National Jewish Health · R35 · FY2024 · HL

Data Generation

$976,018
Jacob David Jaffe · Broad Institute, Inc. · U54 · FY2018 · HG

Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies

$976,015
Harry L Malech · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Molecular strategies for early detection and targeting of cancer

$975,945
Tannishtha Reya · University Of California, San Diego · R35 · FY2021 · CA

Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue

$975,889
Giuseppina Tesco · Tufts University Boston · R01 · FY2020 · AG

Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue

$975,889
Giuseppina Tesco · Tufts University Boston · R01 · FY2021 · AG

Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue

$975,889
Giuseppina Tesco · Tufts University Boston · R01 · FY2023 · AG

Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue

$975,889
Giuseppina Tesco · Tufts University Boston · R01 · FY2024 · AG

Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue

$975,889
Giuseppina Tesco · Tufts University Boston · R01 · FY2022 · AG

Biological correlates of altered brain growth in autism

$975,783
Flora M Vaccarino · Yale University · R01 · FY2010 · MH

Mesenchymal Stem Cell Cardiomyoplasty

$975,618
Johns Hopkins University · U54 · FY2005 · HL

Stromal Regulation of Bone Metastasis

$975,515
Raghu Kalluri · University Of Tx Md Anderson Can Ctr · U54 · FY2014 · CA

The Laboratory of Stem Cell Biology

$975,474
Mahendra Rao · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2012 · AR

Function of human & mouse Beta-globin locus control regions

$975,422
Mark T Groudine · Fred Hutchinson Cancer Research Center · R37 · FY2014 · DK

Animal models to study the role of INK4b loss in human acute myeloid leukemia

$975,365
Linda Wolff · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

The hCNS-HIV/ARV assay system, a platform utilizing human iPSC-neurons/-microglia/-astrocytes to test HIV/AIDS therapeutics for neurotoxicity related to HIV-associated cognitive disroder (HAND)

$975,197
Patrick M McDonough · Vala Sciences, Inc. · R44 · FY2021 · MH

Human Pluripotent Stem Cell Differentiation with Defined O2 & Protein Engagement

$975,069
Clark K Colton · Massachusetts Institute Of Technology · RC1 · FY2010 · DE

Cell plasticity in the origin of gastric carcinogenesis

$975,011
Eunyoung Choi · Vanderbilt University Medical Center · R01 · FY2024 · CA

Preclinical Development of Oxy200 for the Treatment of Osteoporosis

$975,009
Frank Stappenbeck · Max Biopharma, Inc. · R44 · FY2019 · AG

Preclinical Development of Oxy200 for the Treatment of Osteoporosis

$975,009
Frank Stappenbeck · Max Biopharma, Inc. · R44 · FY2018 · AG

Optimization and Characterization of "MYC Degraders" for Pediatric Medulloblastoma

$975,000
Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · R61 · FY2020 · NS

Genomic tools for massively parallel recording of signaling activity at cellular resolution in a brain-wide manner

$975,000
Bushra Raj · University Of Pennsylvania · DP2 · FY2025 · NS